[HTML][HTML] BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance

A Slupianek, C Schmutte, G Tombline… - Molecular cell, 2001 - cell.com
A Slupianek, C Schmutte, G Tombline, M Nieborowska-Skorska, G Hoser, MO Nowicki
Molecular cell, 2001cell.com
RAD51 is one of six mitotic human homologs of the E. coli RecA protein (RAD51-Paralogs)
that play a central role in homologous recombination and repair of DNA double-strand
breaks (DSBs). Here we demonstrate that RAD51 is important for resistance to cisplatin and
mitomycin C in cells expressing the BCR/ABL oncogenic tyrosine kinase. BCR/ABL
significantly enhances the expression of RAD51 and several RAD51-Paralogs. RAD51
overexpression is mediated by a STAT5-dependent transcription as well as by inhibition of …
Abstract
RAD51 is one of six mitotic human homologs of the E. coli RecA protein (RAD51-Paralogs) that play a central role in homologous recombination and repair of DNA double-strand breaks (DSBs). Here we demonstrate that RAD51 is important for resistance to cisplatin and mitomycin C in cells expressing the BCR/ABL oncogenic tyrosine kinase. BCR/ABL significantly enhances the expression of RAD51 and several RAD51-Paralogs. RAD51 overexpression is mediated by a STAT5-dependent transcription as well as by inhibition of caspase-3-dependent cleavage. Phosphorylation of the RAD51 Tyr-315 residue by BCR/ABL appears essential for enhanced DSB repair and drug resistance. Induction of the mammalian RecA homologs establishes a unique mechanism for DNA damage resistance in mammalian cells transformed by an oncogenic tyrosine kinase.
cell.com